|
Workshops on Viral Pathogenesis and Oncogenesis
|
5R13CA095919-06
|
$13,482
|
$674
|
FAN, HUNG
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
UT M.D. Anderson Cancer Center
|
2U10CA045809-19
|
$1,362,206
|
$13,622
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
UCCRC -Cancer Center Support Grant
|
3P30CA014599-32S2
|
$3,773,055
|
$37,731
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
|
UCCRC -Cancer Center Support Grant
|
3P30CA014599-32S3
|
$78,561
|
$786
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
|
TOWARDS A MOUSE MODEL OF CLASSICAL HODGKIN'S DISEASE
|
5R01CA098285-05
|
$398,733
|
$398,733
|
RAJEWSKY, KLAUS
|
IMMUNE DISEASE INSTITUTE, INC.
|
|
The Adverse Effect of Health on Personal Goal Pursuit in Adolescents with Cancer
|
5R03CA126337-02
|
$80,593
|
$24,178
|
Schwartz, Lisa
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Th1/Th2 and Tc1/Tc2 T Cell Subsets in Transplantation Therapy
|
Z01 SC 010288
|
$790,216
|
|
Fowler, Daniel
|
CCR (NCI)
|
|
T cell receptor gene vectors for EBV disease
|
1R43CA130294-01
|
$134,081
|
$67,041
|
Dropulic, Boro
|
LENTIGEN CORPORATION
|
|
Synthesis of Bleomycin Group Antibiotics and Analogues
|
5R01CA077284-09
|
$250,059
|
$82,519
|
Hecht, Sidney
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
|
Studies of Populations Exposed to Occupational Sources of Radiation
|
Z01 CP010133
|
$2,442,184
|
$32,163
|
Linet
|
DCEG (NCI)
|
|
Studies of Medical Radiation and Other Therapeutic Agents
|
Z01 CP010131
|
$1,766,702
|
$39,798
|
Ron
|
DCEG (NCI)
|
|
Studies of Epstein-Barr Virus
|
5R37CA012055-35
|
$431,475
|
$107,869
|
MILLER, I.
|
YALE UNIVERSITY
|
|
Studies of Atomic Bomb Survivors
|
Z01 CP010134
|
$542,516
|
$18,588
|
Land
|
DCEG (NCI)
|
|
Stanford University Cancer Center
|
1P30CA124435-01
|
$1,500,000
|
$15,000
|
WEISSMAN, IRVING
|
STANFORD UNIVERSITY
|
|
St. Vincent Hospital Regional Cancer Center CCOP
|
3U10CA095968-06S1
|
$80,000
|
$1,600
|
SAPHNER, THOMAS
|
ST. VINCENT HOSPITAL
|
|
St. Vincent Hospital Regional Cancer Center CCOP
|
5U10CA095968-06
|
$440,000
|
$8,800
|
SAPHNER, THOMAS
|
ST. VINCENT HOSPITAL
|
|
SPORE in Lymphoma
|
1P50CA126752-01
|
$2,266,618
|
$679,985
|
Heslop, Helen
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Lymphoma
|
3P50CA096888-05S1
|
$1,150,000
|
$575,000
|
AMBINDER, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
South Texas Pediatric Minority Based CCOP
|
3U10CA052771-17S1
|
$75,000
|
$12,000
|
LANGEVIN, ANNE-MARIE
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
South Texas Pediatric Minority Based CCOP
|
5U10CA052771-17
|
$360,000
|
$57,600
|
LANGEVIN, ANNE-MARIE
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
Sioux Community Cancer Consortium
|
5U10CA035103-24
|
$809,999
|
$16,200
|
TSCHETTER, LOREN
|
SIOUX VALLEY CLINIC
|
|
Signal transduction inhibitor therapy for Lymphoma
|
1R01CA127433-01
|
$328,812
|
$164,406
|
Witzig, Thomas
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Regional Oncology Research Center
|
3P30CA006973-45S1
|
$231,549
|
$4,631
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-45S2
|
$126,362
|
$2,527
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-45
|
$7,564,613
|
$151,292
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Receptor -directed therapy
|
Z01 BC 010603
|
$784,643
|
|
Janik, John
|
CCR (NCI)
|
|
Radiologial Physics Center
|
5U10CA010953-39
|
$2,431,121
|
$48,622
|
IBBOTT, GEOFFREY
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Quality Assurance Review Center
|
2U10CA029511-28
|
$1,871,106
|
$37,422
|
FITZGERALD, THOMAS
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
PSYCHOLOGICAL OUTCOME IN CHILDHOOD CANCER SURVIVORS
|
5R01CA106928-04
|
$352,545
|
$70,509
|
KAZAK, ANNE
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Prognostic Genetic Biomarkers for Cancer
|
1R21CA129045-01
|
$214,900
|
$214,900
|
Onel, Kenan
|
UNIVERSITY OF CHICAGO
|
|
Phase I/II study of BCL-family inhibitors in lymphoma
|
Z01 BC 010716
|
$57,991
|
|
Wilson, Wyndham
|
CCR (NCI)
|
|
Phase I Trials of Anti-Cancer Agents
|
5U01CA076576-10
|
$701,378
|
$49,096
|
GREVER, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Pediatric Oncology Branch Clinical Care and Education
|
Z01 BC 010764
|
$1,869,714
|
|
Wayne, Alan
|
CCR (NCI)
|
|
Pathogenesis of Epstein-Barr Virus Infection
|
5R01CA068051-12
|
$403,843
|
$40,384
|
WANG, FREDERICK
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Oklahoma Community Clinical Oncology Program (CCOP)
|
3U10CA045459-21S1
|
$100,000
|
$2,000
|
Lockhart, James
|
WARREN CANCER RESEARCH FOUNDATION
|
|
Oklahoma Community Clinical Oncology Program (CCOP)
|
5U10CA045459-21
|
$540,000
|
$10,800
|
LOCKHART, JAMES
|
WARREN CANCER RESEARCH FOUNDATION
|
|
Ochsner Community Clinical Oncology Program
|
5U10CA035272-24
|
$371,159
|
$7,423
|
KARDINAL, CARL
|
OCHSNER CLINIC FOUNDATION
|
|
Novel Strategies for Immunotherapy fo Cancer
|
5R01CA101795-04
|
$263,284
|
$65,821
|
Wang, Rongfu
|
BAYLOR COLLEGE OF MEDICINE
|
|
North Shore CCOP
|
3U10CA035279-24S1
|
$120,000
|
$2,400
|
VINCIGUERRA, VINCENT
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
|
North Shore CCOP
|
5U10CA035279-24
|
$390,000
|
$7,800
|
VINCIGUERRA, VINCENT
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
|
NM Minority Based Community Clinical Oncology Program
|
5U10CA086780-08
|
$518,248
|
$10,365
|
VERSCHRAEGEN, CLAIRE
|
UNIVERSITY OF NEW MEXICO ALBUQUERQUE
|
|
NK effector mechanisms during NK-lymphoma interactions
|
5R01CA101748-05
|
$266,666
|
$26,667
|
SENTMAN, CHARLES
|
DARTMOUTH COLLEGE
|
|
Nevada Cancer Research Foundation-Community Clinical Oncology Program
|
2U10CA035421-24
|
$650,000
|
$13,000
|
ELLERTON, JOHN
|
SOUTHERN NEVADA CANCER RESEARCH FDN
|
|
Molecular Biomarkers as Predictors of Hodgkin's Disease
|
5R01CA098549-05
|
$286,708
|
$286,708
|
EL-ZEIN, RANDA
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Minority Based Community Clinical Oncology Program
|
2U10CA074811-10
|
$705,000
|
$14,100
|
PEACE, DAVID
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
MCG Minority-Based Community Clinical Oncology Program
|
2U10CA107586-04
|
$450,477
|
$9,010
|
JILLELLA, ANAND
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
|
MCG Minority-Based Community Clinical Oncology Program
|
3U10CA107586-04S1
|
$50,000
|
$1,000
|
Jillella, Anand
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-33S1
|
$110,040
|
$1,100
|
DIASIO, ROBERT
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
3P30CA015083-33S2
|
$98,300
|
$983
|
DIASIO, ROBERT
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Mayo Comprehensive Cancer Center Grant
|
5P30CA015083-33
|
$5,104,634
|
$51,046
|
Diasio, Robert
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
Total relevant funding to Hodgkins disease for this search: $16,493,304
|